Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-13

Clinical Trial Update: Whiplash-induced Thoracic Outlet Syndrome Treated With Botulinum Toxin. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating botulinum toxin for whiplash-induced thoracic outlet syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: King, David, MD | Conditions: Thoracic Outlet Syndrome, Whiplash Injuries | Phase 4 | Status: UNKNOWN